Last reviewed · How we verify
Memantine-matched Placebo capsule — Competitive Intelligence Brief
marketed
Neurology
Small molecule
Live · refreshed every 30 min
Target snapshot
Memantine-matched Placebo capsule (Memantine-matched Placebo capsule) — University of Texas Southwestern Medical Center. This is a placebo capsule formulated to match memantine, an NMDA receptor antagonist used in Alzheimer's disease treatment.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Memantine-matched Placebo capsule TARGET | Memantine-matched Placebo capsule | University of Texas Southwestern Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Memantine-matched Placebo capsule CI watch — RSS
- Memantine-matched Placebo capsule CI watch — Atom
- Memantine-matched Placebo capsule CI watch — JSON
- Memantine-matched Placebo capsule alone — RSS
Cite this brief
Drug Landscape (2026). Memantine-matched Placebo capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/memantine-matched-placebo-capsule. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab